Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Apr 12;172(8):1027-31.
doi: 10.1503/cmaj.1040202.

The 2003 Canadian recommendations for dyslipidemia management: revisions are needed

Douglas G Manuel  1 , Peter Tanuseputro, Cameron A Mustard, Susan E Schultz, Geoffrey M Anderson, Sten Ardal, David A Alter, Andreas Laupacis
Affiliations

The 2003 Canadian recommendations for dyslipidemia management: revisions are needed

Douglas G Manuel et al. CMAJ. .

Erratum in

  • CMAJ. 2005 Jul 19;173(2):133
No abstract available

PubMed Disclaimer

Figures

None
Fig. 1: No. of deaths from coronary artery disease (CAD) prevented over 5 years among people aged 18–74 years receiving statin therapy according to the 2000 and 2003 Canadian recommendations and the 2003 New Zealand guidelines. This assumes that all eligible people were screened and were compliant with the statin therapy recommended and that the drug cost was $1.52 per day. Thick solid rules represent people at high risk for CAD, thinner solid rules represent people at moderate risk, and dotted rules represent people at low risk; for the 2000 Canadian recommendations, the categories of high and very high risk have been combined.
See this image and copyright information in PMC

Comment in

References

    1. Fodor JG, Frohlich JJ, Genest JJ, Jr., McPherson PR. Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. CMAJ 2000;162(10):1441-7. - PMC - PubMed
    1. Genest J, Frohlich J, Fodor G, McPherson R (the Working Group on Hypercholesterolemia and Other Dyslipidemias). Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ 2003;169(9):921-4. - PMC - PubMed
    1. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282(24):2340-6. - PubMed
    1. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22. - PubMed
    1. Alter DA, Manuel DG, Gunraj N, Anderson G, Naylor CD, Laupacis A. Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies. Am J Med 2004;116(8):540-5. - PubMed

Publication types

Substances